Lateral flow assays (LFAs) are paper-based point-of-care (POC) diagnostic tools that are
widely used because of their low cost, ease of use, and rapid format. Unfortunately …

COVID-19 has spread globally since its discovery in Hubei province, China in December
2019. A combination of computed tomography imaging, whole genome sequencing, and …

The great majority of globally circulating pathogens go undetected, undermining patient care
and hindering outbreak preparedness and response. To enable routine surveillance and …

Mitigating global infectious disease requires diagnostic tools that are sensitive, specific, and
rapidly field deployable. In this study, we demonstrate that the Cas13-based SHERLOCK …

Digital health facilitated by wearable/portable electronics and big data analytics holds great
potential in empowering patients with real‐time diagnostics tools and information. The …

The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human,
causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar …

Lateral flow immunoassay (LFIA) technology is a paper-based, point-of-care strip biosensor
designed to detect a specific analyte in a given sample. This type of assay is now of great …

From a home-based pregnancy self-testing kit, lateral flow assays (LFAs) have proliferated
and gained widespread utilization as point-of-care (POC) test kits. Their prevalence is due to …

Fast and widespread diagnosis is crucial to fighting against the outbreak of COVID‐19. This
work surveys the landscape of available and emerging biosensor technologies for COVID …

Point-of-care devices were originally designed to allow medical testing at or near the point of
care by health-care professionals. Some point-of-care devices allow medical self-testing at …